cephalosporin c has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Challa, HPR; Dubbudu, RR; Gupta, A; Kumar, LS; Reddy, PN; Sree, RA; Tirlangi, PK; Wanve, BS; Yadav, BS | 1 |
Egge, SL; Hakki, M; Lewis, JS | 1 |
2 other study(ies) available for cephalosporin c and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Successful Use of Cefepime-Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Cephalosporins; Humans; Microbial Sensitivity Tests; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy | 2023 |
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactamases; Cefepime; Cephalosporins; Humans; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy | 2023 |